Proqr Therapeutics Nv earnings were -$30.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PRQR earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$9.7M, up 7.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PRQR reported annual earnings of -$28.9M, with -7.4% growth. The next PRQR earnings date is May 22, 2025.
Proqr Therapeutics Nv Earnings Reports & History FAQ
What were Proqr Therapeutics Nv's earnings last quarter?
Proqr Therapeutics Nv (NASDAQ: PRQR) reported Q4 2024 earnings per share (EPS) of -$0.09, up 20.51% year over year. Total PRQR earnings for the quarter were -$9.69 million. In the same quarter last year, Proqr Therapeutics Nv's earnings per share (EPS) was -$0.08.
The next PRQR earnings date is Invalid Date. Add PRQR to your watchlist to be reminded of Proqr Therapeutics Nv's next earnings date.
What was PRQR's earnings growth in the past year?
As of Proqr Therapeutics Nv's earnings date in Q2 2025, Proqr Therapeutics Nv's earnings has grown year over year. PRQR earnings in the past year totalled -$30.18 million.
Is Proqr Therapeutics Nv profitable or losing money?
As of the last Proqr Therapeutics Nv earnings report, Proqr Therapeutics Nv is currently losing money. Proqr Therapeutics Nv's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$28.92 million, a 7.44% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.